Network pharmacology identification and <i>in vivo</i> validation of key pharmacological pathways of Qin Jiao for gout and arthritis.

Pharm Biol · 2023 · PMC11001277 · PMID 38069821

Europe PMC DOI

hedged sentence

0.0930

closest p · 1.9× alpha

0.0930

boldest claim

The sentences

a decreasing trendp = 0.093so close (0.05 < p ≤ 0.1)

Compared with the model group, there was a difference in joint swelling at 12h in the colchicine group, and there was a decreasing trend in joint swelling in the QJL group ( p = 0.093).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.